tradepost.ai Logo
Newsletter InsightsSEC AnalysisAI Top20 IndexPricing
Log in
Start free trial
tradepost.ai Logo

Empowering Traders with AI

Quick Links

Newsletter InsightsSEC AnalysisPricingFAQ

Legal

Privacy PolicyCookies PolicySecurity Disclosure PolicyTerms & ConditionsDisclaimer

Copyright © 2025 Dutchcode B.V. All rights reserved.

10-Q - Hypha Labs, Inc. (0001502966) (Filer)

Fri, Jun 13, 8:41 PM (36 days ago)

**Hypha Labs, Inc. (FUNI) Q1 2025 Financial Summary** **Financial Health & Performance:** - **Revenue:** No revenue reported for Q1 2025. - **Profit Margins:** Operating loss of $669,162,000 for Q1 2025, compared to $574,047,000 in Q1 2024. - **Cash Flow:** Net cash used in operating activities was $41,611,000 for the six months ended March 31, 2025, compared to $61,123,000 in 2024. - **Earnings Changes:** Net loss from continuing operations was $641,822,000 for Q1 2025, compared to a net income of $235,821,000 in Q1 2024. **Trends & Uncertainties:** - **Operational Shift:** Hypha Labs transitioned from a cannabis testing lab to developing the Hypha Micropearl accelerator, a home appliance for mushroom production. - **Going Concern:** Substantial doubt about the company's ability to continue as a going concern due to negative working capital and accumulated losses. - **Funding Needs:** The company plans to raise funds through equity or debt securities to complete product development and initial commercial sales. **Future Operations Impact:** - **Product Development:** Focus on designing, developing, and testing the Hypha Micropearl accelerator over the next six months. - **Manufacturing:** Seeking a manufacturing arrangement outside the U.S. for commercial sales. - **Market Entry:** Aims to market the accelerator by the end of 2025, though this is uncertain. **Key Financial Metrics (Q1 2025 vs. Q1 2024):** - **Operating Expenses:** Increased by $95,115,000 due to higher general and administrative expenses and professional fees. - **Other Income:** Decreased by $538,713,000 due to lower gains and higher interest expenses. - **Net Loss:** Increased by $877,643,000 due to higher operating expenses and lower other income. **Conclusion:** Hypha Labs, Inc. is in a transitional phase, shifting from cannabis testing to mushroom production technology. The company faces significant financial challenges and uncertainties but is actively seeking funding and market entry strategies for its new product.